{
    "applicationNumber": "BR 11 2021 018545-3",
    "filingDate": "18/03/2020",
    "grantDate": null,
    "title": "M\u00c9TODO PARA ELIMINAR OU INIBIR O CRESCIMENTO DE C\u00c9LULAS CANCEROSAS EM UM PACIENTE QUE TEM C\u00c2NCER E USO DE UMA DROGA BIOATIV\u00c1VEL DE NQO1 EM COMBINA\u00c7\u00c3O COM UM SEGUNDO AGENTE",
    "nationalPhaseDate": [
        "17/09/2021"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2020/023250",
        "pctDate": "18/03/2020",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/819,870",
            "priorityDate": "18/03/2019"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2647"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2658"
        },
        {
            "code": "25.7",
            "description": "Altera\u00e7\u00e3o de Sede Deferida",
            "bulletinNumber ": "2666"
        }
    ],
    "inventors": [
        "XIN FU",
        "XIUMEI HUANG",
        "DAVID BOOTHMAN",
        "PAUL J HERGENROTHER",
        "XIAOGUANG LI",
        "LINGXIANG JIANG"
    ],
    "holders": [
        80864,
        110234,
        96574
    ],
    "ipcCodes": [
        "C12Q 1/68"
    ]
}